A web-blog (formerly known as Stu's Views and MS News), now published by MS Views and News, a patient advocacy organization. The information on this blog helps to Empower those affected by Multiple Sclerosis globally, with education, information, news and community resources.
~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Thursday, July 14, 2016
Stress Management May Prevent MS Brain Lesions - MedicineNet
July 11, 2012 -- Teaching MS patients how to deal with stress can improve their quality of life -- and may also prevent or slow down formation of new brain lesions, according to a new study.
Patients with multiple sclerosis who attendedstress management therapy sessions for six months had fewer new brain lesions from disease flare-ups and slower disease progression during their treatment, Northwestern University researcher David C. Mohr, PhD, and colleagues found.
The findings, published in the July 11 issue of the journal Neurology, add to evidence that stress management can slow MS disease activity.
"People who got the stress management training had significant reductions in the incidence of new brain lesions while enrolled in the weekly sessions," Mohr tells WebMD.
ut the improvement disappeared when the weekly sessions ended, suggesting that more sustained therapy may be needed, he says.
Stress Management and MS
Mohr says stress management therapy may be a useful addition to MS drugs. He has spent more than a decade researching the impact of depression and stress on MS progression.